Safety and Efficacy of Intrathecal Rituximab in Patients With Multiple Sclerosis
Clinical trial NCT05078177 · UNKNOWN
Trial details
- NCT number
- NCT05078177
- Sponsor
- St. Petersburg State Pavlov Medical University
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-21
- Primary completion
- 2022-12-21
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.